Echidna Therapeutics is focused on glycosyltransferases as a novel targets for anticancer therapies. A new paradigm in human biology is that the proteins which do the essential work for the body are regulated by chains of sugars added to them by glycosyltransferases and in cancer excess activity dri...See more
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Address:
null
LOW
spending power
